These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15677320)

  • 21. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
    Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC
    Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular cloning and functional study of rat estrogen receptor-related receptor gamma in rat prostatic cells.
    Lui K; Huang Y; Choi HL; Yu S; Wong KB; Chen S; Chan FL
    Prostate; 2006 Nov; 66(15):1600-19. PubMed ID: 16927302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The dual, opposing roles of estrogen in the prostate.
    Ellem SJ; Risbridger GP
    Ann N Y Acad Sci; 2009 Feb; 1155():174-86. PubMed ID: 19250203
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential expression of estrogen receptor beta (ERbeta) and its C-terminal truncated splice variant ERbetacx as prognostic predictors in human prostatic cancer.
    Fujimura T; Takahashi S; Urano T; Ogawa S; Ouchi Y; Kitamura T; Muramatsu M; Inoue S
    Biochem Biophys Res Commun; 2001 Dec; 289(3):692-9. PubMed ID: 11726203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histochemistry of steroid receptors in prostatic diseases.
    Pertschuk LP; Zava DT; Gaetjens E; Macchia RJ; Wise GJ; Kim DS; Brigati DJ
    Ann Clin Lab Sci; 1979; 9(3):225-9. PubMed ID: 380450
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Progress in the study of estrogen and estrogen receptors in the hematopoietic and immune system].
    Zhang QH; Cao J; Hu YZ; Huang YH; Xiong XY; Lu SY; Wei GZ
    Sheng Li Ke Xue Jin Zhan; 2004 Jul; 35(3):277-80. PubMed ID: 15469106
    [No Abstract]   [Full Text] [Related]  

  • 27. Regarding "Prostatic hormonal carcinogenesis is mediated by in situ estrogen production and estrogen receptor alpha signaling".
    Friedman AE
    FASEB J; 2009 May; 23(5):1285; author reply 1285-6. PubMed ID: 19406847
    [No Abstract]   [Full Text] [Related]  

  • 28. [Promotor hypermethylation of E-cadherin, p16 and estrogen receptor in prostate carcinoma].
    Yao Q; He XS; Zhang JM; He J
    Zhonghua Nan Ke Xue; 2006 Jan; 12(1):28-31. PubMed ID: 16483154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of ERalpha and ERbeta in prostate cancer.
    Linja MJ; Savinainen KJ; Tammela TL; Isola JJ; Visakorpi T
    Prostate; 2003 May; 55(3):180-6. PubMed ID: 12692783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of serum ceruloplasmin levels in prostate diseases: preliminary investigation of the effect of therapeutic estrogens on serum levels of this protein].
    Bélanger L
    Union Med Can; 1971 Aug; 100(8):1554-62. PubMed ID: 5561247
    [No Abstract]   [Full Text] [Related]  

  • 31. Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.
    Modugno F; Weissfeld JL; Trump DL; Zmuda JM; Shea P; Cauley JA; Ferrell RE
    Clin Cancer Res; 2001 Oct; 7(10):3092-6. PubMed ID: 11595700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantitative GSTP1 methylation clearly distinguishes benign prostatic tissue and limited prostate adenocarcinoma.
    Harden SV; Guo Z; Epstein JI; Sidransky D
    J Urol; 2003 Mar; 169(3):1138-42. PubMed ID: 12576869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oestrogen imprinting causes nuclear changes in epithelial cells and overall inhibition of gene transcription and protein synthesis in rat ventral prostate.
    Augusto TM; Bruni-Cardoso A; Damas-Souza DM; Zambuzzi WF; Kühne F; Lourenço LB; Ferreira CV; Carvalho HF
    Int J Androl; 2010 Oct; 33(5):675-85. PubMed ID: 19925618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of androgen, estrogen (ER alpha and ER beta), and progesterone receptor expression in human prostate cancer by real-time quantitative reverse transcription-polymerase chain reaction assays.
    Latil A; Bièche I; Vidaud D; Lidereau R; Berthon P; Cussenot O; Vidaud M
    Cancer Res; 2001 Mar; 61(5):1919-26. PubMed ID: 11280747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of estrogen in normal male function: clinical implications for patients with prostate cancer on androgen deprivation therapy.
    Wibowo E; Schellhammer P; Wassersug RJ
    J Urol; 2011 Jan; 185(1):17-23. PubMed ID: 21074215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical estrogen receptor demonstration in the prostate and prostate cancer.
    Seitz G; Wernert N
    Pathol Res Pract; 1987 Dec; 182(6):792-6. PubMed ID: 3438207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental oestrogenization and prostatic neoplasia.
    Santti R; Pylkkänen L; Newbold R; McLachlan JA
    Int J Androl; 1990 Apr; 13(2):77-80. PubMed ID: 2345039
    [No Abstract]   [Full Text] [Related]  

  • 39. Maternal Dietary Vitamin D Does Not Program Systemic Inflammation and Bone Health in Adult Female Mice Fed an Obesogenic Diet.
    Villa CR; Chen J; Wen B; Sacco SM; Taibi A; Ward WE; Comelli EM
    Nutrients; 2016 Oct; 8(11):. PubMed ID: 27792161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Maternal vitamin D beneficially programs metabolic, gut and bone health of mouse male offspring in an obesogenic environment.
    Villa CR; Chen J; Wen B; Sacco SM; Taibi A; Ward WE; Comelli EM
    Int J Obes (Lond); 2016 Dec; 40(12):1875-1883. PubMed ID: 27698344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.